Filter
479
Filtered Results: 479
Text search:
drug
stability
testing
Featured
Recommendations
39
New Publications
122
Language
Document type
No document type
316
Guidelines
58
Studies & Reports
57
Manuals
28
Strategic & Response Plan
10
Fact sheets
4
Situation Updates
3
Training Material
2
Infographics
1
Countries / Regions
India
22
South Africa
17
Kenya
15
Uganda
15
Liberia
13
Western and Central Europe
12
Nigeria
11
Tanzania
11
Zambia
11
Global
10
Ethiopia
10
Sierra Leone
8
Malawi
8
Rwanda
7
Zimbabwe
6
Cambodia
6
Asia
6
Bangladesh
6
Nepal
5
Ukraine
5
Ghana
5
Eastern Europe
5
Namibia
5
Botswana
5
Indonesia
4
Mozambique
3
USA
3
Latin America and the Carribbean
3
Congo, Democratic Republic of
3
Middle East and North Africa
3
South Sudan
3
Lesotho
2
Syria
2
Senegal
2
Guinea
2
West and Central Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Russia
2
Iraq
2
Tajikistan
1
Colombia
1
Australia
1
China
1
Albania
1
Burkina Faso
1
Malaysia
1
Philippines
1
Africa
1
Western Pacific Region
1
United Kingdom
1
East and Southern Africa
1
Vietnam
1
Moldova
1
Sudan
1
Yemen
1
Myanmar / Burma
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
193
Clinical Guidelines
42
Pharmacy & Technologies
18
Public Health
16
Women & Child Health
16
Key Resources
14
Capacity Building
6
Toolboxes
HIV
63
Mental Health
39
TB
34
Pharmacy
31
COVID-19
25
AMR
16
NTDs
15
Ebola & Marburg
12
Rapid Response
11
Refugee
6
Caregiver
6
Health Financing Toolbox
5
Conflict
5
Planetary Health
4
NCDs
4
Specific Hazards
3
Natural Hazards
3
Global Health Education
3
Disability
1
Cholera
1
Social Ethics
1
Malaria
1
Zika
1
African Health Sciences 2013; 13(2): 219 - 232 http://dx.doi.org/10.4314/ahs.v13i2.4
UNAIDS 2018 / Guidance
Guidance for policy-makers, and people living with, at risk of or affected by HIV
Psychatry & Pediatrics
Chapter I.3
This Training module on malaria elimination has been developed by WHO to support health professionals in planning, managing, monitoring and evaluating malaria elimination programmes
Position Statement
Diabetes Care2018;42(Suppl. 1):S1–S194.
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands).
Monkeypox (MPX) does not spread easily between people. Human-to-human transmission occurs through close contact ...
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safety gaps across all core components of health systems at all levels.
The rapid review ‘Implications of the COVID-19 pandemic for patient safety’ ex...
Fourth Edition
Key questions
What is already known?
Critical illness is common throughout the world and COVID-19 has caused a global surge of critically ill patients.
There are large gaps in the quality of care for critically ill patients, especially in low-staffed and low-resourced settings, and mortal...
The intended purpose of this compendium is to provide program managers, organizations, and policy makers with a menu of indicators to better “know their HIV epidemic/know their response” from a gender perspective. The indicators in the compendium are all either part of existing indicators used i...
National Statistical Committee of the Kyrgyz Republic Bishkek, Kyrgyz Republic
Ministry of Health Bishkek, Kyrgyz Republic
MEASURE DHS
ICF International Calverton, Maryland, U.S.A.
This Training module on malaria elimination has been developed by WHO to support health professionals in planning, managing, monitoring and evaluating malaria elimination programmes.
Supporting exercises: These files are necessary for participants to complete a number of exercises listed in the man...
Meeting of the Neglected Tropical Diseases Strategic and Technical Advisory
Group’s Monitoring and Evaluation Subgroup on Disease-specific Indicators
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de...
